The role of trastuzumab in the management of salivary ductal carcinomas

AJ Perissinotti, ML Pierce, MB Pace…�- Anticancer�…, 2013 - ar.iiarjournals.org
Background: Salivary ductal carcinoma (SDC) is a high-grade malignancy, and molecular
studies show frequent overexpression of human epidermal growth factor receptor 2 (HER2)�…

The role of trastuzumab in the management of salivary ductal carcinomas

AJ Perissinotti, ML Pierce, MB Pace…�- Anticancer�…, 2013 - mdanderson.elsevierpure.com
Background: Salivary ductal carcinoma (SDC) is a high-grade malignancy, and molecular
studies show frequent overexpression of human epidermal growth factor receptor 2 (HER2)�…

The role of trastuzumab in the management of salivary ductal carcinomas.

AJ Perissinotti, MB Pace, A El-Naggar, MS Kies…�- Anticancer�…, 2013 - europepmc.org
Background Salivary ductal carcinoma (SDC) is a high-grade malignancy, and molecular
studies show frequent overexpression of human epidermal growth factor receptor 2 (HER2)�…

[PDF][PDF] The Role of Trastuzumab in the Management of Salivary Ductal Carcinomas

AJ PERISSINOTTI, MLEE PIERCE…�- ANTICANCER�…, 2013 - academia.edu
Background: Salivary ductal carcinoma (SDC) is a high-grade malignancy, and molecular
studies show frequent overexpression of human epidermal growth factor receptor 2 (HER2)�…

[CITATION][C] The role of trastuzumab in the management of salivary ductal carcinomas

AJ Perissinotti�- Anticancer Res, 2013 - cir.nii.ac.jp

[PDF][PDF] The Role of Trastuzumab in the Management of Salivary Ductal Carcinomas

AJ PERISSINOTTI, MLEE PIERCE…�- ANTICANCER�…, 2013 - ar.iiarjournals.org
Background: Salivary ductal carcinoma (SDC) is a high-grade malignancy, and molecular
studies show frequent overexpression of human epidermal growth factor receptor 2 (HER2)�…

The role of trastuzumab in the management of salivary ductal carcinomas

AJ Perissinotti, ML Pierce, MB Pace…�- Anticancer�…, 2013 - pubmed.ncbi.nlm.nih.gov
Background Salivary ductal carcinoma (SDC) is a high-grade malignancy, and molecular
studies show frequent overexpression of human epidermal growth factor receptor 2 (HER2)�…